NASDAQ

Zentalis Pharmaceuticals, Inc. (ZNTL)

♥ 690 Thanks from members

Live price chart, market sentiment, and community perspectives for Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Camilla EricksonFounder: David WroblewskiLeadership: Kamal Fadili (CEO)Holder: Baker Bros. AdvisorsHolder: Fidelity ManagementHolder: Vanguard GroupCamonsertibZN-c3Oncology Therapeutics#Zentalis Pharmaceuticals#ZNTL#biotech stock#cancer therapeutics#NASDAQ ZNTL